跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,554 条关于
“O3R-5671”
全部
35,554
临床试验
35,120
药物
247
机构
7
资讯
180
9个月前
Onco3R Therapeutics Reports Positive Phase 1 Data for Novel SIK3 Inhibitor O3R-5671 in Autoimmune Disease Treatment
去年
Onco3R Therapeutics Receives Regulatory Approval for First-in-Human Trial of Novel SIK3 Inhibitor O3R-5671
7个月前
Crohn's Disease Clinical Trials Show Promising Pipeline with Novel Therapies Advancing Through Development
上个月
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer to Advance First-in-Class SIK3 Inhibitor COL-5671
4个月前
Coultreon Biopharma Secures $125M Series A to Advance Novel SIK3 Inhibitor for Autoimmune Diseases
去年
mRNA Cancer Vaccines: Emerging Prospects in Immunotherapy
去年
Structure Therapeutics Advances Oral Amylin Agonist ACCG-2671 for Obesity Treatment
去年
China Medical System Gains Exclusive Rights to Gout Drug ABP-671
3年前
LG Chem Completes $571 Million AVEO Acquisition to Accelerate US Cancer Market Entry
去年
Global Biotechnology Market Projected to Reach $5.71 Trillion by 2034, Driven by AI-Powered Drug Discovery and Tissue Engineering
第 1 页,共 18 页
上一页
下一页